16 employees
PROTEINA is a developer of a cancer diagnosis technology intended to detect drug resistance signals.
2015
$17M
from 4 investors over 4 rounds
PROTEINA raised $17M on July 5, 2021
Investors: LB Investment, GNTech Venture Capital | 지앤텍벤처투자, AJU IB INVESTMENT and Timefolio Asset Management